NCT02976519View on ClinicalTrials.gov

BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

August 29, 2018

Study Completion Date

August 29, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

BI 443651

twice daily

DRUG

Placebo

twice daily

Trial Locations (5)

13353

Charité - Universitätsmedizin Berlin, Berlin

60596

IKF Pneumologie GmbH & Co. KG, Frankfurt

81241

Lungenärztliche Praxis, München-Pasing

BT9 6AD

Celerion Inc, Belfast

M23 9QZ

The Medicines Evaluation Unit, Manchester

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY